Element Biosciences, Inc. today unveiled five new products to better serve customers’ low to medium-throughput needs and expand the functionality and versatility of its benchtop sequencer.
| New options expand the benefits of AVITI to fit an even wider range of customers and applications SAN DIEGO, Aug. 17, 2023 /PRNewswire/ -- Element Biosciences Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, today unveiled five new products to better serve customers’ low to medium-throughput needs and expand the functionality and versatility of its benchtop sequencer.
As more researchers are turning to genomics and the needs of labs across the world are evolving, this new product suite will bring AVITI’s industry leading technology to an even wider range of customers, including those who need more operational flexibility, less throughput, or access to longer read applications. These products, which are available now, include:
“A more versatile mix of flow cell capacities on the AVITI means we can migrate almost all of our routine sequencing activities - NGS services, product QC, and R&D - to a single instrument and workflow without the logistics issues of complicated batch management,” said Jacob Enk, Ph.D., Director of Research, Development, and Applications at Daicel Arbor Biosciences. “This relieves routine headaches for us and allows us to concentrate more on answering important research questions.” “Element is continuously innovating to expand access to high quality, affordable, on-demand sequencing to more customers, including labs that have lower throughput needs, run applications that require longer read lengths, or have limited CapEx budget,” said Francisco Garcia, PhD, SVP of Informatics at Element Biosciences. “With these new products, whatever your genomics needs are, the AVITI System is always the perfect fit.” This news comes on the heels of a series of key innovations for Element in the year since launching the AVITI System. In June, Element launched Cloudbreak, improvements to its chemistry that reduce run times, increase accuracy and enable even more applications. In May, Element announced its partnership with Amazon Omics to provide simple, powerful, and cost-effective analysis workflows. In January, Element announced a new throughput-based option for its AVITI System that provides the highest quality sequencing on a benchtop for as low as $200 a genome. About Element Biosciences, Inc. Media Contacts:
SOURCE Element Biosciences |
View original content to download multimedia:
